Eminence Capital’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-435,454
| Closed | -$65.5M | – | 49 |
|
|
2025
Q1 | $65.5M | Sell |
435,454
-192,018
| -31% | -$28.9M | 1.1% | 37 |
|
|
2024
Q4 | $116M | Sell |
627,472
-376,000
| -37% | -$69.4M | 1.77% | 29 |
|
|
2024
Q3 | $198M | Buy |
+1,003,472
| New | +$198M | 2.79% | 10 |
|
|
2021
Q1 | – | Sell |
-67,994
| Closed | -$17M | – | 74 |
|
|
2020
Q4 | $17M | Buy |
+67,994
| New | +$17M | 0.16% | 70 |
|
|
2020
Q3 | – | Sell |
-126,539
| Closed | -$22.1M | – | 78 |
|
|
2020
Q2 | $22.1M | Buy |
+126,539
| New | +$22.1M | 0.22% | 67 |
|